TELESIS BIO News

8-K: Current report

Aug 31 05:33

8-K: Current report

Aug 29 05:03

8-K: Current report

Aug 21 04:34

10-Q: Q2 2024 Earnings Report

Aug 8 18:24

8-K: Telesis Bio Reports Second Quarter and First Half 2024 Financial Results

Aug 8 04:22

4: Statement of changes in beneficial ownership of securities-Director Krueger Todd

Jul 27 04:12

4: Statement of changes in beneficial ownership of securities-Director Hodges Michael R.

Jul 27 04:10

4: Statement of changes in beneficial ownership of securities-Director Hlavinka Sarah E.

Jul 27 04:10

4: Statement of changes in beneficial ownership of securities-Director Golub Steven J

Jul 27 04:10

4: Statement of changes in beneficial ownership of securities-Director Weissman James B

Jul 27 04:09

3: Initial statement of beneficial ownership of securities-Director Krueger Todd

Jul 26 04:17

3: Initial statement of beneficial ownership of securities-Director Golub Steven J

Jul 26 04:17

3: Initial statement of beneficial ownership of securities-Director Hlavinka Sarah E.

Jul 26 04:17

3: Initial statement of beneficial ownership of securities-Director Weissman James B

Jul 26 04:16

3: Initial statement of beneficial ownership of securities-Director Hodges Michael R.

Jul 26 04:15

SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Michael P. Rubin(47.7%),Northpond Ventures, LP(46.5%), etc.

Jul 19 05:46

SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Novalis LifeSciences Investments II, L.P.(19.99%),Novalis LifeSciences Investments II GP, LLC(19.99%), etc.

Jul 19 05:36

8-K: Current report

Jul 19 05:01

8-K: Current report

Jun 13 05:03

SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Michael P. Rubin(47.6%),Northpond Ventures, LP(46.4%), etc.

Jun 11 08:44